CompoAtlas

Serenopro

Natural health product licensed in Canada

Licence holder
Nutri-Dyn Products Ltd. DBA Professional Health Products
NPN or DIN-HM
80027055
Status
Inactive licence
Licence date
23 August 2011
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Prunus africana

Source : Écorce (tige)

Extraction ratio : 4:1

Dry plant equivalent : 400 mg

100 mgNot calculated
Lycopène tout trans

Source : Solanum lycopersicum - Chair (fruit)

7 mgNot calculated

Non-medicinal ingredients

Hypromellose

PopulationAgeQuantity per servingFrequency
Adultes de sexe masculinNot specified1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Saw palmetto is used in herbal medicine to help relieve the urologic symptoms associated with mild to moderate benign prostatic hyperplasia. Lycopene helps to support prostate health; provides antioxidants for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80027055

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line